The recently traced Omicron variant of COVID-19 could run a parallel but separate course to the Delta variant in the U.S., affecting a different target population: COVID-recovered and partially vaccinated Americans, writes Peter Hotez, noting the knowns and unknowns at the start of December.
Read his op-ed for the Daily Beast (subscription required).
Dec. 10, 2021, 2:16 p.m.
Ana S. Iltis, Ph.D., is a nonresident scholar in the Center for Health and Biosciences. She is the director of the Center for Bioethics, Health and Society and professor of philosophy at Wake Forest University. Iltis also holds an appointment …
Maude Rowland Cuchiara, Ph.D., is a nonresident scholar for the Science and Technology Policy Program. Cuchiara actively works with the International Stem Cell Policy Program to research and write science policy reports and peer-reviewed publications. She is specifically interested …
June 21, 2022
Across the country, firearm-related injuries and deaths are on the rise — especially among youth …
